SCHEMBL23079045

SCHEMBL23079045

BC(=O)c1cccc(C)c1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
HSD17B10 Q99714 3/20 0.47
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HPGD P15428 2/20 0.47
KMT2A Q03164 3/20 0.46
TRPA1 O75762 2/20 0.46
LMNA P02545 2/20 0.46
MEN1 O00255 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
AKR1B10 O60218 1/20 0.46
ABCB11 O95342 1/20 0.46
DHFR P00374 1/20 0.46
MPO P05164 1/20 0.46
CYP1A2 P05177 1/20 0.46
CHRM1 P11229 1/20 0.46
AKR1B1 P15121 1/20 0.46
PTGS1 P23219 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30933674 0.82 ESR1 (0.49) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL1135931 0.82 ALDH1A1 (0.63) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL160022 0.82 ESR1 (0.49) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL9864607 0.81 ESR1 (0.52) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL310386 0.81 KMT2A (0.52) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL29515031 0.81 KMT2A (0.52) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL20169819 0.80 TRPA1 (0.48) HSD17B10ALDH1A1KDM4EHPGDKMT2A
Hydrochloric Acid SCHEMBL27700838 0.80 ESR1 (0.47) ESR1ESR2HSD17B10ALDH1A1KDM4E
SCHEMBL28191351 0.80 ESR1 (0.47) ESR1ESR2HSD17B10ALDH1A1KDM4E
Iodide SCHEMBL27448066 0.80 ESR1 (0.47) ESR1ESR2HSD17B10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021045879-A1 SYNTHESIS OF DEUTERATED ALDEHYDES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-03-11 WO disclosed
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 AUSPEX PHARMACEUTICALS, INC. 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160346270-A1 BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 SLC18A2, SLC6A2, SLC18A1 ESR1 3799/4885ESR2 2478/4885HSD17B10 625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.